- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Alternative Capital and Credit Funds
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- Careers
- News & Insights
- About
- Languages
Thomas J. Spulak
Insight 57 results
Article · Source: Law360
June 25, 2020
Congress Could Still Pass Cannabis Legislation In 2020
Client Alert
June 10, 2020
New Flexibilities Enacted in Paycheck Protection Program (PPP)
Client Alert
May 6, 2020
Congressional Oversight of COVID-19 Serological Testing
Client Alert
April 27, 2020
With New Select Investigative Subcommittee, House Democrats Double Down on COVID-19 Oversight
Client Alert
April 27, 2020
Healthcare Provider Stimulus: Update on Public Health and Social Services Emergency Fund
Client Alert
April 20, 2020
Congressional Oversight During COVID-19
Client Alert
March 20, 2020
Second Coronavirus Aid Package
Client Alert
March 10, 2020
FDA Releases Progress Report Regarding Enforcement Discretion Policy on Hemp-Derived Cannabidiol (CBD)
Client Alert
January 16, 2020
Congress Holds Hearing on Current & Future Federal Cannabis Policies
Client Alert
October 1, 2019
Cannabis Banking Bill Clears U.S. House of Representatives
Energy Law Exchange
April 15, 2019
The Climate Change Debate--A New Direction
Newsletter
April 9, 2019
Energy Newsletter – April 2019